Richard H. Friedman, Chairman and Chief Executive Officer, Stanley G. Rosenbaum, Executive Vice President and Chief Financial Officer, and Richard M. Smith, President and Chief Operating Officer, will host the call.
In a release, the Company noted event details:
Interested parties may participate in the conference call by dialing 800-920-2986 (US), or 212-231-2900 (International), 5-10 minutes prior to the start of the call. A replay of the conference call will be available from 12 p.m. Eastern Time on Friday, October 30, through 12 p.m. Eastern Time on November 13, by dialing 800-633-8284 (US), or 402-977-9140 (International), and entering reservation #21440281. An audio web cast and archive of the conference call will also be available under the investor relations section of the BioScrip website at bioscrip.com.
BioScrip, Inc. is a specialty pharmaceutical healthcare organization that partners with patients, physicians, healthcare payors and pharmaceutical manufacturers to provide access to medications and management solutions to optimize outcomes for chronic and other complex healthcare conditions.
((Comments on this story may be sent to health@closeupmedia.com))

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index